PAIGE LOVELACE: Open Payments
NPI 1285038562 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 94 payments from 19 companies in 2025. Trend: 2023 $1,571 · 2024 $2,688 · 2025 $1,987
Food & beverage: $1,944Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $323 |
| Lilly USA, LLC | 11 | $284 |
| Galderma Laboratories, L.P. | 22 | $267 |
| Amgen Inc. | 9 | $245 |
| ABBVIE INC. | 12 | $179 |
| Janssen Biotech, Inc. | 6 | $138 |
| UCB, Inc. | 5 | $118 |
| PFIZER INC. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
Products named: Rhapsido, NEMLUVIO, TALTZ, TREMFYA, OTEZLA, SKYRIZI, Bimzelx, CIBINQO.
Industry payments across RI — which companies pay providers there.
